Cellectar Biosciences, Inc. (CLRB)

NASDAQ: CLRB · Real-Time Price · USD

2.510

-0.020 (-0.79%)

At close: Aug 31, 2026, 4:00 PM EDT

2.559

+0.049 (1.95%)

After-hours: Aug 31, 2026, 6:28 PM EDT

Cellectar Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	33.99	13.2	23.29	9.56	19.87	35.7
Cash & Short-Term Investments	33.99	13.2	23.29	9.56	19.87	35.7
Cash Growth	207.89%	-43.34%	143.48%	-51.85%	-44.36%	-37.54%
Prepaid Expenses	0.88	0.84	0.96	0.89	0.66	0.87
Total Current Assets	34.88	14.04	24.25	10.45	20.53	36.57
Property, Plant & Equipment	1.74	0.91	1.19	1.59	0.98	0.55
Other Long-Term Assets	0.02	0.03	0.03	0.03	0.08	0.08
Total Assets	36.64	14.98	25.47	12.08	21.59	37.2

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	5.22	1.44	4.11	9.18	2.56	1.41
Accrued Expenses	-	2.48	2.17	-	2.91	2.44
Current Portion of Leases	0	0.1	0.08	0.06	0.05	0.14
Other Current Liabilities	0.02	0.73	3.03	16.12	5.98	-
Total Current Liabilities	5.24	4.75	9.39	25.36	11.5	3.99
Long-Term Leases	1.53	0.31	0.41	0.49	0.55	0.17
Total Liabilities	6.77	5.06	9.8	25.85	12.05	4.16

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	311.59	277.15	261.12	182.92	168.14	182.56
Retained Earnings	-281.72	-269.13	-247.34	-202.76	-159.99	-150.9
Total Common Equity	29.87	8.02	13.77	-19.84	8.15	31.66
Shareholders' Equity	29.87	9.92	15.68	-13.78	9.54	33.05
Total Liabilities & Equity	36.64	14.98	25.47	12.08	21.59	37.2

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	1.53	0.41	0.49	0.55	0.6	0.3
Net Cash (Debt)	32.46	12.79	22.79	9.01	19.26	35.4
Net Cash Growth	206.61%	-43.91%	152.94%	-53.22%	-45.59%	-37.61%
Net Cash Per Share	5.45	4.90	18.41	22.12	81.90	191.31
Filing Date Shares Outstanding	9.45	4.24	1.54	1.08	0.32	0.2
Total Common Shares Outstanding	8.25	4.24	1.54	0.69	0.31	0.2
Working Capital	29.64	9.29	14.86	-14.91	9.03	32.58
Book Value Per Share	3.62	1.89	8.97	-28.69	26.06	155.46
Tangible Book Value	29.87	8.02	13.77	-19.84	8.15	31.66
Tangible Book Value Per Share	3.62	1.89	8.97	-28.69	26.06	155.46
Machinery	-	-	-	-	0.8	0.58
Leasehold Improvements	-	-	-	-	0.31	0.31

SEC Filings: 10-K · 10-Q